Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Study shows curcumin enhances antiretroviral delivery and reduces inflammation and oxidative stress in HIV, offering potential improvements in treating HIV-associated neurocognitive disorders.

US hospitals forecast 9% capex growth to support elective procedure backlog: survey

Dive Brief: U.S. hospitals expect to increase capital spending by around 9% next year and buy equipment for use in elective procedures delayed by COVID-19,

December 6, 2023

Point Biopharma’s closely watched prostate cancer radiopharmaceutical study disappoints, Lilly again extends offer

Point Biopharma’s radiopharmaceutical prostate cancer treatment staved off disease progression or death by 3.5 months compared to hormone therapy in a closely watched Phase III

December 19, 2023

Gene therapy’s double-edged sword: Breakthrough treatments face manufacturing and efficacy

Research explores the advancements, challenges, and economic implications of gene therapy for various diseases, including inherited blood disorders, malignancies treated with CAR-T cells, and diseases

November 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.